Verano Holdings (VRNO) Retained Earnings (2024 - 2025)
Verano Holdings' (VRNO) quarterly Retained Earnings came in at $1.7 billion in Q4 2025, up 322.73% year-on-year from $412.9 million in Q4 2024, and up 322.73% on a QoQ basis from -$783.6 million in Q4 2024.
Verano Holdings (VRNO) Retained Earnings (2024 - 2025) Analysis & Trends
Verano Holdings (VRNO) has 2 years of Retained Earnings data on file, last reported at $1.7 billion in Q4 2025.
- On a quarterly basis, Retained Earnings rose 322.73% year-over-year to $1.7 billion in Q4 2025; TTM through Dec 2025 was $1.7 billion, a 322.73% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 322.73% from the prior year.
- Retained Earnings for Q4 2025 stood at $1.7 billion, up from -$783.6 million in the prior quarter.
- Over the last five years, Retained Earnings for VRNO reached as high as $1.7 billion in Q4 2025 and fell as low as -$783.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.75 Bn |
| Dec 31, 2024 | -783.61 Mn |